Evidence map›Paper›PMID 40103575›Full record

ArticleBiomaterials research2025

Natural Polyphenol-Mediated Inhibition of Ferroptosis Alleviates Oxidative Damage and Inflammation in Acute Liver Injury.

Yangjing Su, Yunong Zeng, Minjie Zhou, Meihui Liao, Ping Qin, Rong Wu, Jiaochan Han, Xiaoqi Liang, Ze Wang, Jingjing Jiang and 11 more

Abstract read
In one paragraph

Article in Biomaterials research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Yangjing SuCenter for Drug Research and Development, Guangdong Provincial Key Laboratory for Research and Evaluation of Pharmaceutical Preparations, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Yunong ZengSchool of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Minjie ZhouDepartment of Organ Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Meihui LiaoCenter for Drug Research and Development, Guangdong Provincial Key Laboratory for Research and Evaluation of Pharmaceutical Preparations, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Ping QinSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Rong WuSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Jiaochan HanGuangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China.
Xiaoqi LiangSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Ze WangSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Jingjing JiangSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Zhichao YuSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Xintao HuangSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Kaixin DingSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Peiheng GuoSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Yi HeDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510665, China.
Ying DuConsun Pharmaceutical Group, Guangzhou 510765, China.
Tingting DuanConsun Pharmaceutical Group, Guangzhou 510765, China.
Haitao YuanCenter for Drug Research and Development, Guangdong Provincial Key Laboratory for Research and Evaluation of Pharmaceutical Preparations, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Yuewei GeSchool of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Ali ChenCenter for Drug Research and Development, Guangdong Provincial Key Laboratory for Research and Evaluation of Pharmaceutical Preparations, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Wei XiaoKey Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong Pharmaceutical University, Guangzhou 510006, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetaminophen (APAP) overdose has long been recognized as the main cause of drug-induced liver injury (DILI), characterized by glutathione (GSH) depletion and reactive oxygen species (ROS) accumulation, leading to ferroptosis and inflammatory responses. There is an urgent need for liver-protective agents to combat ferroptosis, modulate oxidative stress, and ameliorate inflammation. Catechin, a well-known polyphenol compound, has been shown to have antioxidant potential. However, its protective role on APAP-induced liver injury (AILI) has not been elucidated. In this study, we evaluated the modulating effects of catechin on AILI and observed that catechin attenuated liver injury by reducing inflammation. Mechanistically, catechin alleviated hepatic oxidative stress by inhibiting ROS accumulation, malondialdehyde (MDA) production, and GSH depletion. Furthermore, catechin, as a hepatic injury reparative agent, could counteract APAP-induced hepatocyte ferroptosis by activating the xCT/GPX4 pathway, and is expected to be a novel natural inhibitor of ferroptosis. Additionally, the transcriptomic results indicated that the inhibition of

Identifiers

PMID40103575
PMCPMC11913781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.